# Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana

> **NCT00403117** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 49 (actual)

## Conditions studied

- Marijuana Use

## Interventions

- **DRUG:** Placebo + Inactive Marijuana (0% THC)
- **DRUG:** Placebo + Active Marijuana (3.27% THC)
- **DRUG:** Naltrexone 12 Mg+ Active Marijuana (3.27% THC)
- **DRUG:** Naltrexone 25 Mg + Active Marijuana (3.27% THC)
- **DRUG:** Naltrexone 50 Mg+ Active Marijuana (3.27% THC)
- **DRUG:** Naltrexone 100 Mg+ Active Marijuana (3.27% THC)
- **DRUG:** Naltrexone 12 Mg + Inactive Marijuana (0% THC)
- **DRUG:** Naltrexone 25 Mg + Inactive Marijuana (0% THC)
- **DRUG:** Naltrexone 50 Mg + Inactive Marijuana (0% THC)
- **DRUG:** Naltrexone 100 Mg + Inactive Marijuana (0% THC)

## Key facts

- **NCT ID:** NCT00403117
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-05
- **Final completion:** 2010-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403117, "Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00403117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*